mRNA, BioNTech
Digest more
A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
Some vaccine advisers under Health and Human Services Secretary Robert F. Kennedy Jr had been seeking to potentially stop recommending mRNA shots, but that plan is no ...
Better mRNA release inside cells boosts vaccine and gene editing performance, enabled by redesigned lipid molecules that grip ...
A settlement provides a massive windfall for Arbutus and Roivant and avoids a worst-case scenario for Moderna.
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.
The panel is scheduled to meet on March 18 and 19, but the meeting could be postponed if a federal judge sides with medical groups suing the Trump administration over its sweeping changes to vaccine ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results